PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsLidofenin
Lidofenin
Technescan (lidofenin) is a small molecule pharmaceutical. Lidofenin was first approved as Technescan hida on 1986-10-31.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
technescan hdpNew Drug Application2022-12-20
technescan mag3New Drug Application2022-12-13
technescan pypNew Drug Application2024-06-07
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V09: Diagnostic radiopharmaceuticals
— V09D: Hepatic and reticulo endothelial system diagnostic radiopharmaceuticals
— V09DA: Technetium (99mtc) compounds
— V09DA03: Technetium (99mtc) lidofenin
HCPCS
No data
Clinical
Clinical Trials
19 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Heart failureD006333EFO_0003144I50———1—1
Diabetes mellitusD003920EFO_0000400E08-E13———1—1
Sickle cell anemiaD000755EFO_0000697D57———1—1
Beta-thalassemiaD017086Orphanet_848D56.1———1—1
ThalassemiaD013789EFO_1001996D56———1—1
HemochromatosisD006432EFO_1000642E83.11———1—1
HemosiderosisD006486—————1—1
Abdominal painD015746EFO_0003766R10.9———1—1
Neoplasm metastasisD009362EFO_0009708————1—1
InfectionsD007239EFO_0000544————1—1
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hematologic neoplasmsD019337———11——2
NeoplasmsD009369—C80——1——1
Hematopoietic stem cell transplantationD018380————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RecurrenceD012008———1———1
Graft vs host diseaseD006086—D89.81—1———1
Peripheral blood stem cell transplantationD036102———1———1
Lymphocyte transfusionD017710———1———1
LeukemiaD007938—C95—1———1
Lymphoid leukemiaD007945—C91—1———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatocellular carcinomaD006528—C22.0————22
Liver neoplasmsD008113EFO_1001513C22.0————22
Liver failureD017093—K72.9————22
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.81————11
Fatty liverD005234EFO_0003934—————11
CholecystitisD002764—K81————11
Acalculous cholecystitisD042101EFO_1000790—————11
DyskinesiasD020820—G24————11
Biliary dyskinesiaD001657EFO_0007169—————11
CarcinomaD002277—C80.0————11
Show 7 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLidofenin
INNlidofenin
Description
Lidofenin is an amino acid amide.
Classification
Small molecule
Drug classdiagnostic aids ((phenylcarbamoyl) methyl iminodiacetic acid derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Cc1cccc(C)c1NC(=O)CN(CC(=O)O)CC(=O)O
Identifiers
PDB—
CAS-ID59160-29-1
RxCUI—
ChEMBL IDCHEMBL1400608
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDEK22QV7701 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 3,660 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
477 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use